blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2508204

EP2508204 - Remedies for diseases caused by vascular contraction or dilation [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.07.2015
Database last updated on 14.09.2024
Most recent event   Tooltip27.10.2017Lapse of the patent in a contracting state
New state(s): BE		published on 29.11.2017  [2017/48]
Applicant(s)For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
[2012/41]
Inventor(s)01 / Nakade, Shinji
c/o Ono Pharmaceutical Co., Ltd.
17-2, Wadai
Tsukuba-shi Ibaraki 300-4247 / JP
02 / Suzuki, Hidehiro
c/o Ono Pharmaceutical Co., Ltd.
17-2, Wadai
Tsukuba-shi Ibaraki 300-4247 / JP
03 / Habashita, Hiromu
c/o Ono Pharmaceutical Co., Ltd.
1-1, Sakurai 3-chome
Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
 [2014/34]
Former [2012/41]01 / Nakade, Shinji
c/o Ono Pharmaceutical Co., Ltd.
17-2, Wadai
Tsukuba-shi Ibaraki 300-4247 / JP
02 / Suzuki, Hidehiro
c/o Ono Pharmaceutical Co., Ltd.
17-2, Wadai
Tsukuba-shi Ibaraki 300-4247 / JP
03 / Habashita, Hiromu
c/o Ono Pharmaceutical Co., Ltd.
17-2, Wadai
Tsukuba-shi Ibaraki 300-4247 / JP
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[N/P]
Former [2012/41]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Application number, filing date12005031.525.06.2003
[2012/41]
Priority number, dateJP2002018554626.06.2002         Original published format: JP 2002185546
[2012/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2508204
Date:10.10.2012
Language:EN
[2012/41]
Type: A3 Search report 
No.:EP2508204
Date:12.12.2012
Language:EN
[2012/50]
Type: B1 Patent specification 
No.:EP2508204
Date:24.09.2014
Language:EN
[2014/39]
Search report(s)(Supplementary) European search report - dispatched on:EP12.11.2012
ClassificationIPC:A61K45/00, A61K31/437, A61K31/445, A61P9/00, A61P9/06, A61P9/10, A61P9/12, A61P9/14, A61P13/12, A61P25/06, A61P43/00, C07D211/48, C07D471/04
[2012/41]
CPC:
C07D471/04 (EP,US); A61K31/437 (EP,US); A61K31/445 (EP,US);
A61P11/06 (EP); A61P13/12 (EP); A61P25/06 (EP);
A61P29/00 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/06 (EP); A61P9/08 (EP); A61P9/10 (EP);
A61P9/12 (EP); A61P9/14 (EP); C07D211/48 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2012/41]
TitleGerman:Mittel für Krankheiten, die durch vaskuläre Kontraktion oder Dilatation verursacht sind[2014/15]
English:Remedies for diseases caused by vascular contraction or dilation[2012/41]
French:REMEDES POUR LES MALADIES PROVOQUEES PAR LA CONTRACTION OU LA & xA;DILATATION VASCULAIRE[2014/15]
Former [2012/41]Abhilfen für Krankheiten, die durch vaskuläre Kontraktion oder Dilatation verursacht sind
Former [2012/41]Remèdes pour les maladies provoquées par la contraction ou la dilatation vasculaire
Examination procedure06.07.2012Examination requested  [2012/41]
12.06.2013Amendment by applicant (claims and/or description)
28.08.2013Despatch of a communication from the examining division (Time limit: M04)
27.12.2013Reply to a communication from the examining division
11.04.2014Communication of intention to grant the patent
08.08.2014Fee for grant paid
08.08.2014Fee for publishing/printing paid
08.08.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP03761797.4  / EP1522314
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030761797) is  14.07.2010
Opposition(s)25.06.2015No opposition filed within time limit [2015/36]
Fees paidRenewal fee
06.07.2012Renewal fee patent year 03
06.07.2012Renewal fee patent year 04
06.07.2012Renewal fee patent year 05
06.07.2012Renewal fee patent year 06
06.07.2012Renewal fee patent year 07
06.07.2012Renewal fee patent year 08
06.07.2012Renewal fee patent year 09
06.07.2012Renewal fee patent year 10
27.06.2013Renewal fee patent year 11
27.06.2014Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.06.2003
AT24.09.2014
BE24.09.2014
BG24.09.2014
CY24.09.2014
CZ24.09.2014
DK24.09.2014
EE24.09.2014
ES24.09.2014
FI24.09.2014
IT24.09.2014
MC24.09.2014
NL24.09.2014
RO24.09.2014
SE24.09.2014
SI24.09.2014
SK24.09.2014
TR24.09.2014
GR25.12.2014
PT26.01.2015
[2017/46]
Former [2017/39]HU25.06.2003
AT24.09.2014
BG24.09.2014
CY24.09.2014
CZ24.09.2014
DK24.09.2014
EE24.09.2014
ES24.09.2014
FI24.09.2014
IT24.09.2014
MC24.09.2014
NL24.09.2014
RO24.09.2014
SE24.09.2014
SI24.09.2014
SK24.09.2014
TR24.09.2014
GR25.12.2014
PT26.01.2015
Former [2016/12]AT24.09.2014
CY24.09.2014
CZ24.09.2014
DK24.09.2014
EE24.09.2014
ES24.09.2014
FI24.09.2014
IT24.09.2014
MC24.09.2014
NL24.09.2014
RO24.09.2014
SE24.09.2014
SI24.09.2014
SK24.09.2014
GR25.12.2014
PT26.01.2015
Former [2016/09]AT24.09.2014
CY24.09.2014
CZ24.09.2014
DK24.09.2014
EE24.09.2014
ES24.09.2014
FI24.09.2014
IT24.09.2014
MC24.09.2014
NL24.09.2014
RO24.09.2014
SE24.09.2014
SK24.09.2014
GR25.12.2014
PT26.01.2015
Former [2015/37]AT24.09.2014
CY24.09.2014
CZ24.09.2014
DK24.09.2014
EE24.09.2014
ES24.09.2014
FI24.09.2014
IT24.09.2014
NL24.09.2014
RO24.09.2014
SE24.09.2014
SK24.09.2014
GR25.12.2014
PT26.01.2015
Former [2015/35]AT24.09.2014
CY24.09.2014
CZ24.09.2014
DK24.09.2014
EE24.09.2014
ES24.09.2014
FI24.09.2014
NL24.09.2014
RO24.09.2014
SE24.09.2014
SK24.09.2014
GR25.12.2014
PT26.01.2015
Former [2015/25]AT24.09.2014
CY24.09.2014
CZ24.09.2014
EE24.09.2014
ES24.09.2014
FI24.09.2014
NL24.09.2014
RO24.09.2014
SE24.09.2014
SK24.09.2014
GR25.12.2014
PT26.01.2015
Former [2015/23]CY24.09.2014
CZ24.09.2014
EE24.09.2014
ES24.09.2014
FI24.09.2014
NL24.09.2014
RO24.09.2014
SE24.09.2014
SK24.09.2014
GR25.12.2014
PT26.01.2015
Former [2015/22]CY24.09.2014
FI24.09.2014
NL24.09.2014
RO24.09.2014
SE24.09.2014
GR25.12.2014
PT26.01.2015
Former [2015/16]CY24.09.2014
FI24.09.2014
NL24.09.2014
SE24.09.2014
GR25.12.2014
Former [2015/11]CY24.09.2014
FI24.09.2014
SE24.09.2014
GR25.12.2014
Former [2015/09]FI24.09.2014
SE24.09.2014
Documents cited:Search[X]WO9931267  (SEPRACOR INC [US]) [X] 1,6 * the whole document *;
 [XI]WO0197786  (HOFFMANN LA ROCHE [CH]) [X] 1-4,6-8,10 * page 109; example 343 * * page 111; example 354 * * page 6, line 20 - page 7, line 3 * [I] 5,9;
 [X]WO0205819  (SMITHKLINE BEECHAM CORP [US], et al) [X] 1,6-10 * page 27, lines 33-36; claims 2,3 * * page 32, lines 22-31 * * claim 5 *;
 [XP]WO03045313  (MERCK & CO INC [US], et al) [XP] 1,6-8,10* page 153; claim 6; compounds 242, 243 *;
 [E]WO03051274  (ASTRAZENECA AB [SE], et al) [E] 1,6-10 * page 14; compound 23 * * page 1, line 7 *;
 [X]  - PANDEY B R ET AL, "Central nervous system depressant, analgesic and monoamine oxidase inhibitory properties of substituted piperidines", RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, PJD PUBLICATIONS LTD., WESTBURY, NY, US, (19840101), vol. 43, no. 1, ISSN 0034-5164, pages 173 - 176, XP008145805 [X] 1,6-8 * page 175; table I *
by applicantUS2868691
 US3095355
 WO0103739
 JP2001261575
 WO0198301
    - SCIENCE, (1990), vol. 248, page 1653
    - STROKE, (2001), vol. 32, page 2913
    - BRITISH J. PHARMACOL., (2000), vol. 130, page 1871
    - EUR. J. NEUROSCI., (2001), vol. 14, page 203
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.